ACUTA CAPITAL PARTNERS, LLC Holdings
ACUTA CAPITAL PARTNERS, LLC is an investment fund managing more than 232.22M US dollars. The largest holdings include Apellis Pharmaceuticals, Aadi Bioscience and BELLUS Health. In Q3 2022 the fund bought assets of total value of 65.5M US dollars and sold assets of total value of 36.89M US dollars.
ACUTA CAPITAL PARTNERS, LLC portfolio value:
$232.22M
portfolio value
ACUTA CAPITAL PARTNERS, LLC quarter portfolio value change:
+13.76%
quarter
ACUTA CAPITAL PARTNERS, LLC 1 year portfolio value change:
-34.19%
1 year
ACUTA CAPITAL PARTNERS, LLC 3 years portfolio value change:
+23.43%
3 years
ACUTA CAPITAL PARTNERS, LLC 5 years portfolio value change:
+29.93%
5 years
ACUTA CAPITAL PARTNERS, LLC portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q1 2016 | 31086000 | 48120000 |
| Q2 2016 | 64446000 | 44637000 |
| Q3 2016 | 63847000 | 7959000 |
| Q4 2016 | 63140000 | 51333000 |
| Q1 2017 | 80276000 | 41445000 |
| Q2 2017 | 78747000 | 89926000 |
| Q3 2017 | 130497000 | 25862000 |
| Q4 2017 | 94630000 | 34455000 |
| Q1 2018 | 143625000 | 64211000 |
| Q2 2018 | 87764000 | 47050000 |
| Q3 2018 | 8870000 | 248825000 |
| Q4 2018 | -2822000 | 124236000 |
| Q1 2019 | 79270000 | 855000 |
| Q2 2019 | 92340000 | 19238000 |
| Q3 2019 | 17894000 | 147222000 |
| Q4 2019 | 228081000 | 4352000 |
| Q1 2020 | 54089000 | 203307000 |
| Q2 2020 | 185933000 | 46649000 |
| Q3 2020 | 141775000 | 149872000 |
| Q4 2020 | 129914000 | 60480000 |
| Q1 2021 | 77676000 | 162624000 |
| Q2 2021 | 19253000 | 64852000 |
| Q3 2021 | 96318000 | 38999000 |
| Q4 2021 | 54239000 | 85799000 |
| Q1 2022 | 35227000 | 40275000 |
| Q2 2022 | 21503000 | 40958000 |
| Q3 2022 | 65496000 | 36886000 |
ACUTA CAPITAL PARTNERS, LLC 13F holdings
| Stock |
|---|
| Portfolio share: 16.29% Portfolio value: 37.83M Avg. open price: $34.25 Current price: $49.41 P/L: +44.27% Bought +3.55% shares Q1 2022 |
| Portfolio share: 11.25% Portfolio value: 26.13M Avg. open price: $12.32 Current price: $13.42 P/L: +8.89% Bought +20.92% shares Q3 2022 |
| Portfolio share: 6.54% Portfolio value: 15.19M Avg. open price: $8.55 Current price: $10.02 P/L: +17.25% Bought +76.29% shares Q3 2022 |
| Portfolio share: 5.83% Portfolio value: 13.53M Avg. open price: $34.96 Current price: $4.45 P/L: -87.27% Bought +3.72% shares Q3 2022 |
| Portfolio share: 4.35% Portfolio value: 10.11M Avg. open price: $5.78 Current price: $21.89 P/L: +278.62% Bought +4.47% shares Q2 2022 |
| Portfolio share: 4.24% Portfolio value: 9.83M Avg. open price: $13.18 Current price: $38.83 P/L: +194.62% Bought +21.11% shares Q2 2022 |
| Portfolio share: 3.64% Portfolio value: 8.44M Avg. open price: $11.14 Current price: $10.04 P/L: -9.92% Bought +0.07% shares Q1 2021 |
| Portfolio share: 3.36% Portfolio value: 7.8M Avg. open price: $16.32 Current price: $25.44 P/L: +55.92% Bought +58.35% shares Q3 2022 |
| Portfolio share: 3.23% Portfolio value: 7.51M Avg. open price: $13.41 Current price: $36.66 P/L: +173.41% Sold -17.25% shares Q2 2022 |
| Portfolio share: 3.20% Portfolio value: 7.44M Avg. open price: $14.82 Current price: $26.84 P/L: +81.13% Bought +55.00% shares Q3 2022 |
| Portfolio share: 3.19% Portfolio value: 7.40M Avg. open price: $34.96 Current price: $4.45 P/L: -87.27% N/A Q3 2022 |
| Portfolio share: 3.16% Portfolio value: 7.32M Avg. open price: $12.15 Current price: $15.82 P/L: +30.16% Bought +13.19% shares Q2 2022 |
| Portfolio share: 3.15% Portfolio value: 7.31M Avg. open price: $80.3 Current price: $92.75 P/L: +15.50% Bought +10.90% shares Q3 2022 |
| Portfolio share: 2.71% Portfolio value: 6.28M Avg. open price: $12.86 Current price: $28.09 P/L: +118.47% Bought +47.54% shares Q3 2022 |
| Portfolio share: 2.48% Portfolio value: 5.75M Avg. open price: $235.64 Current price: $273.72 P/L: +16.16% Bought +111.54% shares Q3 2022 |
| Portfolio share: 2.41% Portfolio value: 5.60M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020 |
| Portfolio share: 2.36% Portfolio value: 5.48M Avg. open price: $12.04 Current price: $4.75 P/L: -60.56% Bought +30.58% shares Q3 2022 |
| Portfolio share: 1.98% Portfolio value: 4.58M Avg. open price: N/A Current price: $122.96 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.72% Portfolio value: 4.00M Avg. open price: N/A Current price: $10.52 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.47% Portfolio value: 3.40M Avg. open price: $8.37 Current price: $9.29 P/L: +10.99% Bought +789.06% shares Q3 2022 |
| Portfolio share: 1.30% Portfolio value: 3.02M Avg. open price: $9.7 Current price: $12.37 P/L: +27.53% N/A Q3 2022 |
| Portfolio share: 1.25% Portfolio value: 2.89M Avg. open price: $26.2 Current price: $31.87 P/L: +21.64% Bought +41.30% shares Q3 2022 |
| Portfolio share: 1.22% Portfolio value: 2.82M Avg. open price: $21.76 Current price: $11.4 P/L: -47.62% Sold -42.03% shares Q2 2022 |
| Portfolio share: 1.09% Portfolio value: 2.53M Avg. open price: $14.33 Current price: $15.66 P/L: +9.28% Sold -16.59% shares Q3 2022 |
| Portfolio share: 1.03% Portfolio value: 2.4M Avg. open price: $12.72 Current price: $3.33 P/L: -73.82% Sold -1.48% shares Q2 2022 |
| Portfolio share: 0.89% Portfolio value: 2.06M Avg. open price: N/A Current price: $6.09 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.88% Portfolio value: 2.04M Avg. open price: N/A Current price: $44.33 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.79% Portfolio value: 1.83M Avg. open price: $20.13 Current price: $9.89 P/L: -50.87% Bought +1.31% shares Q3 2022 |
| Portfolio share: 0.77% Portfolio value: 1.78M Avg. open price: $7.74 Current price: $6.56 P/L: -15.26% Bought +10.00% shares Q3 2022 |
| Portfolio share: 0.69% Portfolio value: 1.59M Avg. open price: $10.71 Current price: $11.09 P/L: +3.55% N/A Q3 2022 |
| Portfolio share: 0.63% Portfolio value: 1.47M Avg. open price: $13.23 Current price: $8.03 P/L: -39.33% Sold -0.46% shares Q3 2022 |
| Portfolio share: 0.57% Portfolio value: 1.31M Avg. open price: $3.96 Current price: $1.29 P/L: -67.38% Bought +3.72% shares Q3 2022 |
| Portfolio share: 0.51% Portfolio value: 1.18M Avg. open price: $22 Current price: $14.2 P/L: -35.45% Sold -61.69% shares Q3 2022 |
| Portfolio share: 0.51% Portfolio value: 1.17M Avg. open price: N/A Current price: $8.14 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.49% Portfolio value: 1.14M Avg. open price: N/A Current price: $1.71 P/L: N/A Sold -35.03% shares Q3 2022 |
| Portfolio share: 0.29% Portfolio value: 669K Avg. open price: N/A Current price: $5.43 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.11% Portfolio value: 248K Avg. open price: $105.21 Current price: $98.48 P/L: -6.40% Sold -88.85% shares Q3 2022 |
| Portfolio share: 0.09% Portfolio value: 201K Avg. open price: N/A Current price: $7.49 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.06% Portfolio value: 149K Avg. open price: N/A Current price: $17.77 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.06% Portfolio value: 143K Avg. open price: N/A Current price: $24.25 P/L: N/A N/A Q2 2022 |
| Portfolio share: 0.06% Portfolio value: 136K Avg. open price: N/A Current price: $34.51 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.05% Portfolio value: 108K Avg. open price: N/A Current price: $20.26 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.04% Portfolio value: 98K Avg. open price: N/A Current price: $5.6 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.03% Portfolio value: 60K Avg. open price: N/A Current price: $7.05 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.02% Portfolio value: 56K Avg. open price: $2.81 Current price: $2.09 P/L: -25.62% Bought +3.72% shares Q3 2022 |
| Portfolio share: 0.01% Portfolio value: 15K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2022 |
| Portfolio share: 0.00% Portfolio value: 10K Avg. open price: N/A Current price: $6.77 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $1.94 Current price: $0.12 P/L: -93.59% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $20.04 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $18.38 Current price: $2.94 P/L: -84.01% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.42 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $71.18 Current price: $43.06 P/L: -39.51% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.96 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $33.96 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $30.47 Current price: $15.24 P/L: -49.99% Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.24 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.99 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $0.42 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 59 ACUTA CAPITAL PARTNERS's 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of ACUTA CAPITAL PARTNERS, LLC?
The biggest position of the ACUTA CAPITAL PARTNERS, LLC is Apellis Pharmaceuticals, Inc. (APLS) with 16.29% portfolio share worth of 37.84M US dollars.
Top 5 ACUTA CAPITAL PARTNERS's holdings represent 44.27% of the portfolio:
- Apellis Pharmaceuticals, Inc. (APLS) – 16.29%
- Aadi Bioscience, Inc. (AADI) – 11.25%
- BELLUS Health Inc. (BLU) – 6.54%
- Relmada Therapeutics, Inc. (RLMD) – 5.83%
- IVERIC bio, Inc. (ISEE) – 4.35%
Who is the portfolio manager of ACUTA CAPITAL PARTNERS, LLC?
The portfolio manager of the ACUTA CAPITAL PARTNERS, LLC is .
What is the total asset value of the ACUTA CAPITAL PARTNERS, LLC portfolio?
ACUTA CAPITAL PARTNERS, LLC total asset value (portfolio value) is 232.22M US dollars.
Who is ?
is the portfolio manager of the ACUTA CAPITAL PARTNERS, LLC.
What is (ACUTA CAPITAL PARTNERS, LLC) fund performance?
ACUTA CAPITAL PARTNERS's quarterly performance is +13.76%, annualy -34.19%. In the past 3 years, the value of 's portfolio has increased by +23%. In the past 5 years, the value of the portfolio has increased by +30%.
What is the ACUTA CAPITAL PARTNERS, LLC CIK?
ACUTA CAPITAL PARTNERS's Central Index Key is 0001582844 .